| Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom (NCT00757614) | Cancer Research UK | 2008-02-01 |
| Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation (NCT00889278) | Dartmouth-Hitchcock Medical Center | 2008-02-01 |
| Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders (NCT00740467) | Institut Paoli-Calmettes | 2008-01-01 |
| Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant (NCT00513474) | Massachusetts General Hospital | 2008-01-01 |
| Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia (NCT00625729) | Masonic Cancer Center, University of Minnesota | 2008-01-01 |
| Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin (NCT00577798) | University of Nebraska | 2008-01-01 |
| Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma (NCT00569309) | Ohio State University Comprehensive Cancer Center | 2007-12-12 |
| Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma (NCT00566228) | Mayo Clinic | 2007-12-01 |
| Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation (NCT00591630) | M.D. Anderson Cancer Center | 2007-11-14 |
| Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma (NCT00574496) | Memorial Sloan Kettering Cancer Center | 2007-11-13 |
| Evaluation of KX2-391 in Patients With Advanced Malignancies (NCT00658970) | Athenex, Inc. | 2007-11-01 |
| Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma (NCT00854581) | University of Miami | 2007-11-01 |
| Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma (NCT00561418) | Ohio State University Comprehensive Cancer Center | 2007-11-01 |
| Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM). (NCT00665314) | Genzyme, a Sanofi Company | 2007-11-01 |
| Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma (NCT00598169) | AIDS Malignancy Consortium | 2007-11-01 |
| Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma (NCT00621036) | University of Texas Southwestern Medical Center | 2007-10-19 |
| A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan (NCT00577278) | City of Hope Medical Center | 2007-10-03 |
| GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma (NCT00521014) | Memorial Sloan Kettering Cancer Center | 2007-10-01 |
| KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment (NCT00646139) | Roswell Park Cancer Institute | 2007-10-01 |
| Studying Fentanyl in Patients With Cancer (NCT00899951) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-10-01 |
| Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00521261) | Barbara Ann Karmanos Cancer Institute | 2007-10-01 |
| Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma (NCT00561756) | Memorial Sloan Kettering Cancer Center | 2007-10-01 |
| T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE (NCT00578461) | Baylor College of Medicine | 2007-10-01 |
| Multi-dose-escalation Safety and Pharmacokinetic Study of SAR3419 as Single Agent in Relapsed/Refractory B-cell Non Hodgkin's Lymphoma (NCT00549185) | Sanofi | 2007-10-01 |
| Study of Biomarkers Using Tissue Samples From Older Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab on Clinical Trial ECOG-E4494 (NCT00898157) | ECOG-ACRIN Cancer Research Group | 2007-09-24 |
| Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders (NCT00801931) | Columbia University | 2007-09-06 |
| Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma (NCT00531284) | Amgen | 2007-09-01 |
| A Dose-Escalating Study of Obinutuzumab in Patients With B-lymphocyte Antigen (CD20+) Malignant Disease (GAUGUIN) (NCT00517530) | Hoffmann-La Roche | 2007-09-01 |
| Study of XL228 Administered Intravenously to Subjects With Advanced Malignancies (NCT00526838) | Exelixis | 2007-09-01 |
| PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (NCT00544219) | Swiss Cancer Institute | 2007-09-01 |
| A Study of MabThera (Rituximab) in Primary Central Nervous System Lymphoma. (NCT00517699) | Hoffmann-La Roche | 2007-09-01 |
| Combined CT Colonography and PET Imaging in Mantle Cell Lymphoma (NCT00541424) | M.D. Anderson Cancer Center | 2007-09-01 |
| Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies (NCT00536978) | M.D. Anderson Cancer Center | 2007-09-01 |
| Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma (NCT00474929) | Mayo Clinic | 2007-08-29 |
| Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma (NCT00335140) | Eastern Cooperative Oncology Group | 2007-08-23 |
| Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma (NCT00551239) | CTI BioPharma | 2007-08-01 |
| Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer (NCT00499668) | Vanderbilt-Ingram Cancer Center | 2007-08-01 |
| Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma (NCT00516412) | Swiss Cancer Institute | 2007-08-01 |
| A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL) (NCT00587015) | MedImmune LLC | 2007-08-01 |
| Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma (NCT00589381) | National Institutes of Health Clinical Center (CC) | 2007-08-01 |
| Phase I Trial of PX-478 (NCT00522652) | Cascadian Therapeutics Inc. | 2007-08-01 |
| A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma. (NCT00677105) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-08-01 |
| Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant (NCT00602446) | Masonic Cancer Center, University of Minnesota | 2007-08-01 |
| Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma (NCT00372905) | Northwestern University | 2007-07-24 |
| T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer (NCT00602693) | Masonic Cancer Center, University of Minnesota | 2007-07-23 |
| Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas (NCT00955292) | Cylene Pharmaceuticals | 2007-07-01 |
| Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia (NCT00445497) | Clatterbridge Centre for Oncology | 2007-07-01 |
| Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and Cytarabine (NCT00503594) | Assistance Publique - Hôpitaux de Paris | 2007-07-01 |
| A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment (NCT01561911) | Cancer Research UK | 2007-07-01 |
| Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or Lymphoma (NCT00486135) | Sanofi | 2007-06-01 |
| Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma (NCT00689845) | University Hospital Southampton NHS Foundation Trust | 2007-06-01 |
| Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers (NCT00619645) | University of California, Davis | 2007-06-01 |
| Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma (NCT00569985) | City of Hope Medical Center | 2007-06-01 |
| Rituximab, Bortezomib,Bendamustine , Dexamethasone, Patients With Mantle Cell Lymphoma (NCT00740415) | French Innovative Leukemia Organisation | 2007-06-01 |
| Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies (NCT00473551) | M.D. Anderson Cancer Center | 2007-05-01 |
| Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer (NCT00369564) | University of South Florida | 2007-05-01 |
| Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy (NCT00416624) | Mayo Clinic | 2007-05-01 |
| A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors (NCT00664586) | Erimos Pharmaceuticals | 2007-05-01 |
| Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation (NCT00626626) | Milton S. Hershey Medical Center | 2007-05-01 |
| Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer (NCT00589563) | City of Hope Medical Center | 2007-05-01 |
| A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-02) (NCT00520390) | Enzon Pharmaceuticals, Inc. | 2007-05-01 |
| Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases (NCT00376519) | Masonic Cancer Center, University of Minnesota | 2007-05-01 |
| A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP Only (NCT00451178) | Eli Lilly and Company | 2007-05-01 |
| MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma (NCT00504205) | Astex Pharmaceuticals, Inc. | 2007-05-01 |
| A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01) (NCT00520637) | Enzon Pharmaceuticals, Inc. | 2007-05-01 |
| Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma (NCT00562068) | Cancer Research UK | 2007-05-01 |
| A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies (NCT00475917) | Exelixis | 2007-05-01 |
| Genes in Predicting Outcome of Patients With DLBCL Treated With Rituximab and Combination Chemotherapy (R-CHOP) (NCT00450385) | University of Miami | 2007-04-24 |
| Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496 (NCT00898963) | ECOG-ACRIN Cancer Research Group | 2007-04-18 |
| Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer (NCT00787761) | Northside Hospital, Inc. | 2007-04-01 |
| Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma (NCT00461084) | Memorial Sloan Kettering Cancer Center | 2007-04-01 |
| Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877 (NCT00471367) | AstraZeneca | 2007-04-01 |
| Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma (NCT00478062) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-04-01 |
| Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma (NCT00446095) | Rigel Pharmaceuticals | 2007-04-01 |
| Rituximab Combined With ESHAP in Patients With Relapse or Refractory Diffuse Large B Cell Lymphoma (DLBCL) (NCT00568815) | Fudan University | 2007-04-01 |
| Collecting and Storing Tissue From Young Patients With Cancer (NCT00898755) | Children's Oncology Group | 2007-03-05 |
| Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies (NCT00460460) | AstraZeneca | 2007-03-01 |
| Study on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell Lymphoma (NCT00568607) | Fudan University | 2007-03-01 |
| Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer (NCT00806767) | Institut Paoli-Calmettes | 2007-03-01 |
| Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases (NCT00438958) | The Canadian Blood and Marrow Transplant Group | 2007-03-01 |
| Phase 1 Study of EZN-2968 Weekly in Adult Patients With Advanced Solid Tumors or Lymphoma (NCT00466583) | Enzon Pharmaceuticals, Inc. | 2007-03-01 |
| Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma (NCT00392990) | Northwestern University | 2007-02-06 |
| Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment (NCT00458744) | Children's Oncology Group | 2007-02-01 |
| Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma (NCT00439361) | M.D. Anderson Cancer Center | 2007-02-01 |
| Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma (NCT00513188) | University of Miami | 2007-02-01 |
| Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases (NCT00453206) | Wake Forest University Health Sciences | 2007-02-01 |
| Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma (NCT00377052) | NCIC Clinical Trials Group | 2007-01-16 |
| AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma (NCT00390117) | NCIC Clinical Trials Group | 2007-01-05 |
| Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma (NCT00389818) | AIDS Malignancy Consortium | 2007-01-01 |
| Bevacizumab and Bortezomib in Patients With Advanced Malignancy (NCT00428545) | M.D. Anderson Cancer Center | 2007-01-01 |
| Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases (NCT00424242) | Northwestern University | 2007-01-01 |
| Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma (NCT00433459) | Christine Mauz-Körholz | 2007-01-01 |
| Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant (NCT00900406) | Vanderbilt-Ingram Cancer Center | 2007-01-01 |
| Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant (NCT00964821) | City of Hope Medical Center | 2007-01-01 |
| S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911 (NCT00896922) | SWOG Cancer Research Network | 2007-01-01 |
| Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients (NCT02108444) | Peking University | 2007-01-01 |
| T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant (NCT00651716) | Vanderbilt-Ingram Cancer Center | 2006-12-01 |
| Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies (NCT00410982) | M.D. Anderson Cancer Center | 2006-12-01 |
| Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00425802) | Memorial Sloan Kettering Cancer Center | 2006-11-28 |
| Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma (NCT00039195) | Memorial Sloan Kettering Cancer Center | 2006-11-01 |